BioXcel Therapeutics (BTAI) Notes Payables (2017)
BioXcel Therapeutics (BTAI) recorded quarterly Notes Payables of $371000.0 in Q4 2017.
BioXcel Therapeutics (BTAI) Notes Payables (2017) Analysis & Trends
BioXcel Therapeutics' Notes Payables history runs 1 years deep, the most recent figure standing at $371000.0 for Q4 2017.
- In Q4 2017, Notes Payables changed N/A year-over-year to $371000.0; the TTM figure through Dec 2017 stood at $371000.0 (changed N/A YoY), while the FY2017 annual figure was $371000.0, changed N/A from the prior year.
- Notes Payables was $371000.0 for Q4 2017 at BioXcel Therapeutics.
- In the past five years, Notes Payables ranged from a high of $371000.0 in Q4 2017 to a low of $371000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | BioXcel Therapeutics | 25.46 Mn | 25.46 Mn | -77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 371,000.00 |